ASSOCIATION OF PROTON PUMP INHIBITORS AND THE RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS: A KOREAN NATIONWIDE COHORT STUDY

被引:0
|
作者
Kim, Hyung Joon [1 ]
Kim, Eunju [2 ]
Chang, Jong-In [2 ]
机构
[1] Chung Ang Univ Hosp, Seoul, South Korea
[2] Chung Ang Univ, Gwangmyeong Hosp, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
466
引用
收藏
页码:S340 / S341
页数:2
相关论文
共 50 条
  • [1] Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C
    Kao, Wei-Yu
    Su, Chien-Wei
    Tan, Elise Chia-Hui
    Lee, Pei-Chang
    Chen, Ping-Hsien
    Tang, Jui-Hsiang
    Huang, Yi-Hsiang
    Huo, Teh-Ia
    Chang, Chun-Chao
    Hou, Ming-Chih
    Lin, Han-Chieh
    Wu, Jaw-Ching
    HEPATOLOGY, 2019, 69 (03) : 1151 - 1164
  • [2] RETRACTED: Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study (Retracted Article)
    Choi, Jonggi
    Kim, Hyo Jeong
    Lee, Jayoun
    Cho, Songhee
    Ko, Min Jung
    Lim, Young-Suk
    JAMA ONCOLOGY, 2019, 5 (01) : 30 - 36
  • [3] Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study
    Fu, S. -C.
    Huang, Y. -W.
    Wang, T. -C.
    Hu, J. -T.
    Chen, D. -S.
    Yang, S. -S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1200 - 1209
  • [4] Association between proton pump inhibitors and the risk of hepatocellular carcinoma
    Shao, Y. -H. J.
    Chan, T. -S.
    Tsai, K.
    Wu, S. -Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (04) : 460 - 468
  • [5] Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study
    Kim, Soungmun
    Jeong, Seogsong
    Park, Sun Jae
    Chang, Jooyoung
    Choi, Seulggie
    Cho, Yoosun
    Ahn, Joseph C.
    Lee, Gyeongsil
    Son, Joung Sik
    Park, Sang Min
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [6] Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
    Wu, Chun-Ying
    Lin, Jaw-Town
    Ho, Hsiu J.
    Su, Chien-Wei
    Lee, Teng-Yu
    Wang, Shen-Yung
    Wu, Chuhui
    Wu, Jaw-Ching
    GASTROENTEROLOGY, 2014, 147 (01) : 143 - U249
  • [7] Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study
    Lee, Jayoun
    Kim, Gi-Ae
    Kim, Hyo Jeong
    Cho, Songhee
    Ko, Min Jung
    Lim, Young-Suk
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (08) : 1150 - 1159
  • [8] Use of proton pump inhibitors and risk of cholangitis: a nationwide cohort study
    Min, Yang Won
    Kang, Danbee
    Shin, Ju-Young
    Kang, Minwoong
    Park, Loo Kyung
    Lee, Kwang Hyuck
    Lee, Jong Kyun
    Lee, Kyu Taek
    Rhee, Poong-Lyul
    Kim, Jae J.
    Guallar, Eliseo
    Cho, Juhee
    Lee, Hyuk
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 760 - 768
  • [9] ASSOCIATION BETWEEN VIRAL LOAD AND HEPATOCELLULAR CARCINOMA RISK IN UNTREATED CHRONIC HEPATITIS B PATIENTS : A MULTINATIONAL COHORT STUDY
    Kim, Gi-Ae
    Lim, Young-Suk
    Han, Seungbong
    Choi, Gwang Hyeon
    Choi, Won-Mook
    Choi, Jonggi
    Sinn, Dong Hyun
    Paik, Yong-Han
    Lee, Jeong-Hoon
    Lee, Yun Bin
    Cho, Ju-Yeon
    Heo, Nae-Yun
    Yuen, Man-Fung
    Wong, Vincent Wai-Sun
    Chan, Stephen Lam
    Yang, Hwai-, I
    Chen, Chien-Jen
    HEPATOLOGY, 2023, 78 : S450 - S452
  • [10] Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
    Hwang, In Cheol
    Chang, Jooyoung
    Park, Sang Min
    PLOS ONE, 2018, 13 (09):